Drug Profile
Research programme: Prader-Willi syndrome therapeutics - Levo Therapeutics
Latest Information Update: 16 Jun 2023
Price :
$50
*
At a glance
- Originator Levo Therapeutics
- Class Obesity therapies
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Prader-Willi syndrome
Most Recent Events
- 28 Sep 2021 No recent reports of development identified for research development in Prader-Willi-syndrome in USA
- 11 Aug 2017 Early research in Prader-Willi syndrome in USA before August 2017